Nautilus Biotechnolgy, Inc.

XNAS

Last traded price · USD

$2.30

+0.44%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 15:34 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $2.29
Volume: 3,570
Day's high: —
Day's low: —

In brief

Nautilus Biotechnolgy, Inc. is a US-listed company listed on Nasdaq, valued at about $293M.
Its shares closed at $2.29 on 4 Nov 2026, up 44.0% over the past year.
From India you can buy NAUT in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Nautilus Biotechnolgy, Inc. (NAUT) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole NAUT share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade NAUT options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Ahead of SPY over 1 year
1 month: +29.4% (SPY −1.6%). 3 months: +146.2% (SPY −0.4%). 1 year: +44.0% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: NAUT, SPY · as of 4 Nov 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $2.29 was 36.6% above its 50-day average ($1.68) and 7.9% above its 200-day average ($2.12). It has closed above the 200-day for 13 sessions, since 19 Oct 2026. The 50-day average crossed below the 200-day on 23 Jul 2026, 73 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
42% of the way up its 52-week range
Closed at $2.29 on 4 Nov 2026: 46.9% below the 52-week high of $4.31 (25 Mar 2026) and 172.3% above the low of $0.84 (7 Aug 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Short interest at 4.4% of shares outstanding
5.6M shares were sold short at the 15 Oct 2026 settlement, 4.4% of the 127.4M shares outstanding; covering them would take 1.0 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+29.4%

6 months−22.1%

1 year+44.0%

5 years−59.9%

Newswire

About

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.

Website

Notable moves

November 3, 2025
+39.10%
October 21, 2025
+27.93%
May 13, 2025
+28.22%

Nautilus Biotechnolgy, Inc.

XNAS

Last traded price · USD

$2.30

+0.44%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 15:34 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $2.29
Volume: 3,570
Day's high: —
Day's low: —

In brief

Nautilus Biotechnolgy, Inc. is a US-listed company listed on Nasdaq, valued at about $293M.
Its shares closed at $2.29 on 4 Nov 2026, up 44.0% over the past year.
From India you can buy NAUT in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Nautilus Biotechnolgy, Inc. (NAUT) shares from India?

Do I need the price of a whole NAUT share to invest?

How much can I invest in US stocks in a year?

Can I trade NAUT options or futures?

Insights

Quotes run fifteen minutes behind.

Ahead of SPY over 1 year
1 month: +29.4% (SPY −1.6%). 3 months: +146.2% (SPY −0.4%). 1 year: +44.0% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: NAUT, SPY · as of 4 Nov 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $2.29 was 36.6% above its 50-day average ($1.68) and 7.9% above its 200-day average ($2.12). It has closed above the 200-day for 13 sessions, since 19 Oct 2026. The 50-day average crossed below the 200-day on 23 Jul 2026, 73 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
42% of the way up its 52-week range
Closed at $2.29 on 4 Nov 2026: 46.9% below the 52-week high of $4.31 (25 Mar 2026) and 172.3% above the low of $0.84 (7 Aug 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Short interest at 4.4% of shares outstanding
5.6M shares were sold short at the 15 Oct 2026 settlement, 4.4% of the 127.4M shares outstanding; covering them would take 1.0 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+29.4%

6 months−22.1%

1 year+44.0%

5 years−59.9%

Newswire

About

Website

Notable moves

November 3, 2025
+39.10%
October 21, 2025
+27.93%
May 13, 2025
+28.22%

Nautilus Biotechnolgy, Inc.

Nautilus Biotechnolgy, Inc. in brief

Ahead of SPY over 1 year

Above its 50- and 200-day averages

42% of the way up its 52-week range

Short interest at 4.4% of shares outstanding

Nautilus Biotechnolgy, Inc.

Nautilus Biotechnolgy, Inc. in brief

Ahead of SPY over 1 year

Above its 50- and 200-day averages

42% of the way up its 52-week range

Short interest at 4.4% of shares outstanding